The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

A new collaboration between Becton, Dickinson and Co. and Ypsomed will support the development of a 5.5-milliliter, glass, prefilled syringe designed for use with large-volume autoinjectors. The ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...

The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...

Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe ...

MAINZ, Germany & MENLO PARK, Calif.--(BUSINESS WIRE)--Credence MedSystems and SCHOTT AG have formed a collaboration for the application of Credence Companion® technology with SCHOTT’s pre-fillable ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...